Multivariate Cox regression analyses adjusted for tumor stage including lymph node involvement, grading, hormone receptor and HER2 status revealed sNRP-1 to be an independent prognostic marker for BCSS (p = 0.006; HR 1.98; 95%CI 1.22–3.21). Here, NR4A1 is linked to neoplasm.